Magellan Diagnostics, a Massachusetts-based company, has agreed to settle criminal charges for concealing a malfunction in its lead poisoning tests that resulted in inaccurately low results. The Department of Justice announced that Magellan will pay $42 million in penalties.
From 2013 to 2017, Magellan’s devices, including LeadCare Ultra, LeadCare II, and LeadCare Plus, were widely used, with some being recalled as late as 2021. The malfunction led to falsely low lead level readings, potentially affecting tens of thousands of children. Accurate testing is crucial, especially in cities like Washington, D.C., and Flint, Michigan, which have faced lead contamination issues.
Parents concerned about their children’s exposure should consult their pediatricians. Retesting may be necessary if initial tests were conducted with the affected devices. This case highlights the importance of transparency and accountability in medical testing.
Â
Source:
Source: Original Article
Publish Date: 2024-06-08 06:33:16